Last updated: over 1 year ago
Chemomab Therapeutics Reports FDA Meeting Success: Path to Nebokitug Approval
Chemomab Therapeutics Ltd. announces a successful End-of-Phase 2 meeting with the FDA for Nebokitug, paving the way for potential regulatory approval in Primary Sclerosing Cholangitis.